Management implications associated with switching from vitamin K antagonist anticoagulants to direct oral anticoagulants

被引：0
|
作者：
Pia-Morandeira, Agustin [1 ]
Cinza-Sanjurjo, Sergio [2 ,3 ,4 ]
Portela-Romero, Manuel [4 ,5 ]
机构：
[1] Area Sanitaria Integrada Santiago Compostela, Ctr Saude Noia, La Coruna, Spain
[2] Area Sanitaria Integrada Santiago Compostela, Ctr Saude Porto Son, La Coruna, Spain
[3] Inst Invest Sanitaria Santiago Compostela IDIS, La Coruna, Spain
[4] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain
[5] Area Sanitaria Integrada Santiago Compostela, Ctr Saude Concepcion Arenal, La Coruna, Spain
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2022年 / 75卷 / 04期
关键词：
D O I：
10.1016/j.rec.2021.09.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：345 / 347
页数：3
相关论文
共 50 条
  • [41] Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes
    Rubboli, Andrea
    ITALIAN JOURNAL OF MEDICINE, 2013, 7 : 22 - 28
  • [42] Meta-Analysis of Direct Oral Anticoagulants Compared With Vitamin K Antagonist for Left Ventricle Thrombus
    Mir, Tanveer
    Sattar, Yasar
    Bin Attique, Hassan
    Hussain, Tanveer
    Alraies, M. Chadi
    Sheikh, Mujeeb
    Qureshi, Waqas T.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2022, 35 : 141 - 146
  • [43] Are the Direct Oral Anticoagulants Better for Patients with Low Time in the Therapeutic Range on Vitamin K Antagonist Therapy?
    Schaefer, Jordan K.
    Barnes, Geoffrey D.
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (08) : 791 - 794
  • [44] Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
    Susin Park
    Nam Kyung Je
    International Journal of Arrhythmia, 23 (1)
  • [45] Clinical implications, benefits and pitfalls of using and reversing non-vitamin K antagonist oral anticoagulants
    Moss, Alexandra Sophie
    Dimitropoulous, Gerasimos
    Lip, Gregory Y. H.
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (09) : 833 - 845
  • [46] Hemorrhagic effects of oral anticoagulants: a comparative study between vitamin K antagonists (VKA) and direct oral anticoagulants (DOA)
    Montastruc, J. L.
    Rousseau, V.
    Chebane, L.
    Abadie, D.
    Bondon-Guitton, E.
    Durrieu, G.
    Montastruc, F.
    Bagheri, H.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (10) : 1283 - 1284
  • [47] Hemorrhagic effects of oral anticoagulants: a comparative study between vitamin K antagonists (VKA) and direct oral anticoagulants (DOA)
    J. L. Montastruc
    V. Rousseau
    L. Chebane
    D. Abadie
    E. Bondon-Guitton
    G. Durrieu
    F. Montastruc
    H. Bagheri
    European Journal of Clinical Pharmacology, 2015, 71 : 1283 - 1284
  • [48] Non-Vitamin K Antagonist Oral Anticoagulants An Appeal for Consensus on Terminology
    Lip, Gregory Y. H.
    Camm, A. John
    Hylek, Elaine M.
    Halperin, Jonathan L.
    Weitz, Jeffrey I.
    CHEST, 2014, 145 (05) : 1177 - 1178
  • [49] Non-Vitamin K Antagonist Oral Anticoagulants in the Treatment of Atrial Fibrillation
    Fanaroff, Alexander C.
    Ohman, E. Magnus
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 61 - 75
  • [50] Misdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Primary Care
    Cardoso, Carlos Seica
    Sousa, Joao Andre
    Simoes, Pedro
    Silva, Beatriz
    Albuquerque, Ana
    Esperanca, Ana
    Cibrao, Ana
    Correia, Artur
    Goncalves, Joana
    Mortagua, Joana
    Almeida, Jose Eduardo
    Oliveira, Leonor
    Garcia, Jose
    Duarte, Mariana
    Loureiro, Mariana
    Costa e Silva, Marta
    Fraga, Marta
    Lopes, Paulo
    Brandao, Rui
    Miguel, Susana
    Queiros, Teresa
    Santo, Gustavo
    Silva, Fernando
    Sargento-Freitas, Joao
    CLINICAL THERAPEUTICS, 2020, 42 (06) : 1132 - +
12345